Preloader Close

The Rational for Subtyping Depression in Research and Clinical Settings 

15 December 2023, 11.00-11.45 

Martin Preisig

Lausanne University Hospital Center And University Of Lausanne, Switzerland

Martin Preisig is full Professor at the Department of Psychiatry of the University Hospital of Lausanne, Switzerland and the director of the Psychiatric Epidemiology and Psychopathology Research Center of the department. He graduated from the University of Zurich in 1986. After having completed specialty training in psychiatry in Switzerland, he obtained a Master of Public Health at Yale University in 1994. His main research interests involve the familial aggregation and genetic determinants of psychiatric disorders and the association between psychiatric disorders and cardio-vascular risk factors. He has received several grants from the SNFS to conduct a follow-up study on the offspring of parents with mood disorders and for CoLaus¦PsyCoLaus, a prospective multidisciplinary community study.

Risk and Resilience in Young People at Risk for Mood Disorders

16 December 2023, 11.00-11.45 

Manon Hillegers

Erasmus MC Sophia, Rotterdam, The Netherlands

Prof. dr. Manon Hillegers is an experienced child and adolescent psychiatrist (inter)nationally acknowledge for her expertise in youth (at risk for) bipolar mood and psychotic disorders. She is the chair of the department of child and adolescent psychiatry/psychology at the Erasmus Medical Center in Rotterdam, The Netherlands. As a researcher she is a PI in several longitudinal studies in pediatric populations (MARIO, Generation R, CID & eHealthJunior consortium, PROTECtME) with an interest in phenotyping of emerging psychopathology, risk and resilience mechanisms and eHealth. Currently, she leads 3 large cross-diagnostic offspring cohorts of patients with bipolar, unipolar and psychotic disorders (Dutch Bipolar Offspring study Kinderen Bipolaire Ouders Onderzoek (, BRIDGE ( and MARIO ( In these longitudinal offspring studies besides deep phenotyping with questionnaires and interviews, brain development (sMRI & fMRI), immunological parameters, genetics and ESM measures are included. Her goal is to better understand the trajectories of psychopathology, identify phenotypic risk profiles and develop interventions. Using the knowledge regarding emerging psychopathology obtained from longitudinal studies in high risk populations, she and her team developed a digital tool (Grow It app) to identify and support youngsters with mild emotional problems. She serves as an ESCAP board member since 2018 and was the ESCAP congress president 2022 in Maastricht and is a member of ISBD task forces (offspring, staging, pediatric bipolar disorder).